U.S. Pharmacy Market Size, Share & COVID-19 Impact Analysis, By Type (Branded and Generics); By Therapy Class (Oncology, Anti-diabetics, Autoimmune Diseases, Respiratory, Pain, Nervous System Disorders, Dermatology, Antihypertensive, Mental Health, HIV Antivirals, Multiple Sclerosis, Anticoagulants, Other Cardiovascular, ADHD, GI Products, Viral Hepatitis, Sex Hormones, Antibacterial, Hormonal Contraception, Ophthalmology, and Others), By Setting (Retail Pharmacies, Mail Order/Online Pharmacies, Others), Regional Forecast, 2021-2028

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106306

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Are you interested in exploring our consulting services?

I want to learn more about:

Competitive Intelligence Opportunity Assessment Distribution & Supply Chain Analysis Book a consultation to discuss your needs

Market Entry Strategy Go-to-market Strategy Others (Please specify)

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Chronic and Infectious Diseases in U.S., 2020
2. Key Industry Developments - Mergers, Acquisitions and Partnerships, 2020
3. Introduction of New Products / Approvals (By Major Players)
4. Impact of COVID-19 on U.S. Pharmacy Market
U.S. Pharmacy Market Analysis, Insights and Forecast, 2017-2028
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Type
  1. Branded
  2. Generics
3. Market Analysis, Insights and Forecast – By Therapy Class
  1. Oncology
  2. Anti-diabetics
  3. Autoimmune diseases
  4. Respiratory
  5. Pain
  6. Nervous System Disorders
  7. Dermatology
  8. Antihypertensive
  9. Mental Health
  10. HIV Antivirals
  11. Multiple Sclerosis
  12. Anticoagulants
  13. Other Cardiovascular
  14. ADHD
  15. GI Products
  16. Viral Hepatitis
  17. Sex Hormones
  18. Antibacterial
  19. Hormonal Contraception
  20. Ophthalmology
  21. Others
4. Market Analysis, Insights and Forecast – By Setting
  1. Retail Pharmacies
  2. Mail Order/Online Pharmacies
  3. Others (Non-retail Settings)
Competitive Analysis
1. Key Industry Developments
2. Market Share Analysis (2020)
3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
  1. CVS Health Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  2. Walgreens Boots Alliance, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  3. Cigna (Express Scripts)
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  4. UnitedHealth Group (Optum)
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  5. Walmart Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  6. The Kroger Company
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  7. Rite Aid Corporation
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
  8. Albertsons Companies, Inc.
    1. Overview,
    2. Products,
    3. SWOT,
    4. Recent Developments,
    5. Strategies,
    6. Financials (based on availability)
Strategic Recommendations